v3.24.4
Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Millions
Total
Common Stock Outstanding
Treasury Shares Outstanding
Par Value and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   1,249,213,681        
Beginning balance of treasury stock, (in shares) at Dec. 31, 2021     1,537,468      
Beginning balance at Dec. 31, 2021 $ 69,102   $ (13) $ 73,292 $ (1,365) $ (2,812)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,590         2,590
Other comprehensive income 319       319  
Stock-based compensation 656     656    
Stock issued for employee stock purchase plan (in shares)   2,079,086        
Stock issued for employee stock purchase plan 227     227    
Issuance of vested restricted stock units (in shares)   5,796,891        
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,900,710)        
Shares withheld related to net share settlement of stock awards and stock options (243)     (243)    
Repurchases of common stock (in shares)   (21,361,409) (21,361,409)      
Repurchases of common stock (3,000)   $ (3,000)      
Other, net (in shares)   132,539 17,572      
Other, net 5   $ (3) 9   (1)
Ending balance (in shares) at Dec. 31, 2022   1,233,960,078        
Ending balance of treasury stock, (in shares) at Dec. 31, 2022     22,916,449      
Ending balance at Dec. 31, 2022 69,656   $ (3,016) 73,941 (1,046) (223)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 8,317         8,317
Dividends declared (747)         (747)
Other comprehensive income 82       82  
Stock-based compensation 687     687    
Stock issued for employee stock purchase plan (in shares)   1,771,475        
Stock issued for employee stock purchase plan 210     210    
Issuance of vested restricted stock units (in shares)   6,074,565        
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (2,027,800)        
Shares withheld related to net share settlement of stock awards and stock options (297)     (297)    
Repurchases of common stock (in shares)   (92,925,044) (92,925,044)      
Repurchases of common stock (13,255)   $ (13,255)      
SoftBank contingent shares settlement (in shares) [1]   48,751,557 (48,751,557)      
SoftBank contingent shares settlement [1] 52   $ 6,901 (6,849)    
Other, net (in shares)   202,500 6,887      
Other, net $ 10   $ (3) 13    
Ending balance (in shares) at Dec. 31, 2023 1,195,807,331 1,195,807,331        
Ending balance of treasury stock, (in shares) at Dec. 31, 2023 67,096,823   67,096,823      
Ending balance at Dec. 31, 2023 $ 64,715   $ (9,373) 67,705 (964) 7,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11,339         11,339
Dividends declared (4,302)         (4,302)
Other comprehensive income 107       107  
Stock-based compensation 619     619    
Stock issued for employee stock purchase plan (in shares)   1,519,242        
Stock issued for employee stock purchase plan 191     191    
Issuance of vested restricted stock units (in shares)   4,740,186        
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,552,111)        
Shares withheld related to net share settlement of stock awards and stock options (269)     (269)    
Repurchases of common stock (in shares)   (59,376,922) (59,376,922)      
Repurchases of common stock (11,206)   $ (11,206)      
Ka'ena Acquisition upfront consideration (in shares)   3,264,952        
Ka’ena Acquisition upfront consideration 536     536    
Other, net (in shares)   177,003 20,938      
Other, net $ 11   $ (5) 16    
Ending balance (in shares) at Dec. 31, 2024 1,144,579,681 1,144,579,681        
Ending balance of treasury stock, (in shares) at Dec. 31, 2024 126,494,683   126,494,683      
Ending balance at Dec. 31, 2024 $ 61,741   $ (20,584) $ 68,798 $ (857) $ 14,384
[1] Represents the issuance of the SoftBank Specified Shares pursuant to the Letter Agreement. See Note 16 – Earnings Per Share of the Notes to the Consolidated Financial Statements for more information.